Skip to main content

Table 3 Characterization of BMD and BMC parameters in breast cancer patients (n = 40)

From: Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients

Parameter Basala
(No treatment)
6 monthsa
(After treatment)
Δb p c Confidence Interval
95 %
BMD femoral neck (g/cm2) 1.02 ± 0.1 1.001 ± 0.1 −0.018 <0.001 (−0.026, −0.011)
BMD L2-L4 (g/cm2) 1.19 ± 0.2 1.15 ± 0.1 −0.048 <0.001 (−0.063, −0.033)
BMC (kg) 2.46 ± 0.34 2.43 ± 0.34 −0.032 0.066 (−0.065, 0.002)
  1. BMDBone Mineral Density, BMC Bone Mineral Content
  2. aMean ± SD
  3. bΔ = measurement 2- measurement 1
  4. cpaired t test